Recent fda Articles
For those of us living with cancer, this is what being proactive looks like right now in 4 steps. Because this is no time to lower your defenses.
Despite the remarkable progress in drug development across several populations of cancer, troubling facts have recently emerged about several expensive FDA-approved anticancer drugs.
The Right-to-Try movement—advocates for faster access to potentially life-saving experimental drugs for terminal patients—has gained strong momentum, with the act recently winning easy passage in congress, and, at the time of this article, it is on its way for a senate vote. The legislation is widely anticipated to become law later this year. As of […]